Zemplar and hypercalcaemia 
Zemplar and hypercalcaemia Patient Reports February 10, 2012
Zemplar Side Effects Report #5368323-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on June 15, 2007. Male patient, weighting 135.6 lb, was diagnosed with renal osteodystrophy, cardiovascular event prophylaxis, musculoskeletal pain, hyperphosphataemia, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: back pain
, body temperature increased, c-reactive protein increased, gastroenteritis , hypercalcaemia, left ventricular dysfunction, movement disorder , musculoskeletal pain, spinal osteoarthritis. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, COXTRAL, SEVELAMER HYDROCHLORIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4791937-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 28, 2005. Female patient, 85 years of age, was diagnosed with renal failure chronic, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: bradycardia, cerebrovascular accident, dysphoria, hypercalcaemia, infection
. Zemplar dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, MOXONIDINE, SEVELAMER HYDROCHLORIDE, TITRALAC, PANCORAN TTS, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 09/17/2005.Zemplar Side Effects Report #5416075-7
Zemplar side effect was reported by a Physician from PUERTO RICO on Aug 10, 2007. Male patient, 72 years of age, was diagnosed with renal failure, cardiac failure congestive and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, fall
, hypercalcaemia, subdural haematoma. Zemplar dosage: unknown. During the same period patient was treated with CADUET, CARVEDILOL, IMDUR, LOSARTAN POTASSIUM. Patient was hospitalized. Patient died on 07/20/2007.Zemplar Side Effects Report #5755996-2
Zemplar side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Male patient, 60 years of age, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia. Zemplar dosage: unknown. Patient recovered.
Zemplar Side Effects Report #5755998-6
Zemplar side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Male patient, 30 years of age, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia. Zemplar dosage: unknown. Patient recovered.
Zemplar Side Effects Report #6126623-X
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 17, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.
Zemplar Side Effects Report #6130209-0
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 24, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.
Zemplar Side Effects Report #5065016-3
Zemplar side effect was reported by a Physician from SWITZERLAND on July 20, 2006. Female patient, 80 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthenia, fall
, gait disturbance, hypercalcaemia, malaise. Zemplar dosage: unknown. Patient recovered.Zemplar Side Effects Report #5072985-4
Zemplar side effect was reported by a Physician from AUSTRIA on July 12, 2006. Female patient, 67 years of age, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia, hypothyroidism, diabetes mellitus, gastritis, coronary artery disease
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, SEVELAMER HYDROCHLORIDE, ANTIPHOSPHAT, LEVOTHYROXINE, REPAGLINIDE, PANTOPRAZOLE. Patient recovered.Zemplar Side Effects Report #5200136-1
Zemplar side effect was reported by a Physician from GERMANY on Dec 27, 2006. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic stenosis, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with ALUMINIUM CHLORHYDROXIDE, MOLSIDOMIN, SIMVASTATIN, OMEPRAZOLE, CLOPIDOGREL BISULPHATE, DREISAVIT, CARVEDILOL. Patient was hospitalized. Patient died on 09/04/2006.
Zemplar Side Effects Report #5109515-4
Zemplar side effect was reported by a Physician from GERMANY on Sept 13, 2006. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic stenosis, hypercalcaemia. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 09/04/2006.
Zemplar Side Effects Report #5116346-8
Zemplar side effect was reported by a Physician from GERMANY on Sept 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, confusional state, hypercalcaemia, psychotic disorder
. Zemplar dosage: unknown. Patient recovered.Zemplar Side Effects Report #5190907-2
Zemplar side effect was reported by a Physician from GERMANY on Sept 13, 2006. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic stenosis, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with ALUMINIUM CHLORHYDROXIDE, MOLSIDOMIN, SIMVASTATIN, OMEPRAZOLE, CLOPIDOGREL BISULPHATE, DREISAVIT, CARVEDILOL. Patient was hospitalized. Patient died on 09/04/2006.
Zemplar Side Effects Report #5410926-8
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, weighting 132.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, hypercalcaemia, renal failure acute. Zemplar dosage: unknown. During the same period patient was treated with CINACALCET HYDROCHLORIDE. Patient died on 07/26/2007.
Zemplar Side Effects Report #5567210-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 12, 2007. Female patient, weighting 200.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, FERROVIN, SUPERAMINE, SEVELAMER HYDROCHLORIDE, TITRALAC, NEUROBION, ACENOCOUMAROL, CARVEDILOL. Patient recovered.
Zemplar Side Effects Report #5620066-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 30, 2008. Female patient, weighting 200.2 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine deficiency, hypovitaminosis, atrial fibrillation
, cardiac failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, FERROVIN, SUPERAMINE, NEUROBION, ACENOCOUMAROL, CARVEDILOL. Patient recovered.Zemplar Side Effects Report #5688299-5
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 26, 2008. Female patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FERRIGLUCONATE, FOLIC ACID, DARBEPOETIN ALFA. Patient died on 02/10/2007.Zemplar Side Effects Report #5761565-0
Zemplar side effect was reported by a Physician from GERMANY on May 27, 2008. Female patient, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall
, hypercalcaemia, thrombosis. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, ALUMINIUM HYDROXIDE GEL, COLECALCIFEROL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4986860-4
Zemplar side effect was reported by a Physician from GERMANY on Mar 06, 2006. Female patient, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall
, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, ALUMINIUM HYDROXIDE GEL, COLECALCIFEROL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5021576-X
Zemplar side effect was reported by a Physician from AUSTRIA on Apr 09, 2006. Male patient, 70 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism, renal failure chronic, ph body fluid and was treated with Zemplar. After drug was administered, patient experienced the following side effects: hypercalcaemia, hyperphosphataemia, syncope, treatment noncompliance. Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSPHATE, CALCITRIOL, MIMPARA. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #6079363-X
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2009. Female patient was diagnosed with hyperparathyroidism, vitamin supplementation, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: confusional state, contusion, dizziness
, fall , hemiparesis, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with VITAMIN D, LOTREL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5340846-9
Zemplar side effect was reported by a Physician from GERMANY on May 23, 2007. Male patient, 83 years of age, weighting 185.2 lb, was diagnosed with diabetic neuropathy, dialysis
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall , haematoma, hypercalcaemia, shunt thrombosis, skin laceration. Zemplar dosage: unknown. During the same period patient was treated with ATACANT, PANTOPRAZOLE, VITARENAL, CARBIDOPA, PRIMIDONE, ERYPOETIN, ATRAPHANA. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5284153-1
Zemplar side effect was reported by a Physician from UNITED STATES on Oct 30, 2006. Female patient, 53 years of age, weighting 132.0 lb, was diagnosed with blood calcium decreased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dysgeusia, hypercalcaemia, renal impairment. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, CONDIT, CLONIDINE, CAPTOPRIL. Patient recovered.
Zemplar Side Effects Report #5694011-6
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 27, 2008. Male patient, 84 years of age, was diagnosed with muscle spasms and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abnormal behaviour, acidosis, blood parathyroid hormone increased, blood thyroid stimulating hormone increased, confusional state, disorientation, hypercalcaemia, mental impairment. Zemplar dosage: unknown. During the same period patient was treated with HEPARIN, EPOETIN BETA, SACCHARATED IRON OXIDE, DIAZEPAM, PARENTROVITE, FOLACIN, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5330344-0
Zemplar side effect was reported by a Physician from GERMANY on May 11, 2007. Male patient, 83 years of age, weighting 185.2 lb, was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall
, haematoma, hypercalcaemia, shunt thrombosis, skin laceration. Zemplar dosage: unknown. During the same period patient was treated with ATACANT, PANTOPRAZOLE, VITARENAL, CARBIDOPA, PRIMIDONE, ERYPOETIN, ATRAPHANA, ALFACALCIDOL. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5678980-6
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 20, 2008. Female patient, weighting 154.3 lb, was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FERRIGLUCONATE, FOLIC ACID, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, MADOPAR. Patient died on 02/10/2007.